Trial Profile
The Effect of Sitagliptin on Brown Adipose Tissue and Whole-body Metabolism in Overweight Pre-diabetic Men
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Overweight
- Focus Therapeutic Use
- Acronyms SitaBAT
- 25 Aug 2018 Primary endpoint (The effect of sitagliptin treatment on BAT activity in overweight, pre-diabetic subjects BAT volume and activity will be measured by means of cold-induced 18F-FDG PET-CT scans) has not been met, according to results published in the Diabetologia.
- 25 Aug 2018 Results published in the Diabetologia
- 11 Nov 2016 Status changed from recruiting to completed.